Company / Interest Expense
Dynavax Technologies Corp. Interest Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$6.8M
FY2024
5-year range
$5.0M / $19.1M
FY2020-FY2024
Trend
+0.5%
vs FY2023
Sector context
#30 of 42
Health Care
What the data says
At $7M, Dynavax Technologies Corp.'s interest expense ranks #13 of 42 in the Health Care sector. Increased from $5M to $7M over the past 2 years.
Based on SEC 10-K filings.
$7M in FY2024 with a 5-year CAGR of -16.7%.
Increased from $5M to $7M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -15.3%
- 5-Year CAGR
- -16.7%
- 10-Year CAGR
- -
Sector benchmark
#13 of 42 in Health CareTop 29% of 42This company $6.8M Sector average $305.3M
▼
-97.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -16.7%, indicating a declining trend.
- In FY2024, interest expense increased 0.5% year-over-year.
- Ranks #30 out of 42 companies in the Health Care sector.
- Peak interest expense was recorded in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $6.8M | +0.5% |
| FY2023 | $6.8M | +34.0% |
| FY2022 | $5.0M | -54.9% |
| FY2021 | $11.2M | -41.4% |
| FY2020 | $19.1M | +12.3% |
| FY2019 | $17.0M | +81.8% |
| FY2018 | $9.3M | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | $572.0K | +1534.3% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026